---
title: "Germline and Somatic Variants Independently Shape Risk and Enable Stratification in Immune Cytopen"
id: "medrxiv-14-rare-and-common-germline-and-somatic-variants-shape-immune-cytopenia-risk-and"
canonical_url: "https://medichelpline.com/clinical-feed/medrxiv-14-rare-and-common-germline-and-somatic-variants-shape-immune-cytopenia-risk-and"
content_type: "clinical_feed_article"
specialty: "Hematology"
source_name: "medRxiv (Clinical Preprints)"
source_url: "https://www.medrxiv.org/content/10.64898/2026.08.26.26361484v1?rss=1"
published_at: "2026-08-31T12:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Germline and Somatic Variants Independently Shape Risk and Enable Stratification in Immune Cytopen
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/medrxiv-14-rare-and-common-germline-and-somatic-variants-shape-immune-cytopenia-risk-and
- **Specialty:** [Hematology](https://medichelpline.com/clinical-feed/hematology.md)
- **Primary Source:** medRxiv (Clinical Preprints)
- **Source URL:** [Original Journal Publication](https://www.medrxiv.org/content/10.64898/2026.08.26.26361484v1?rss=1)
- **Published At:** 2026-08-31T12:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- The study analyzed the genetic contributors to **immune cytopenia** using whole-genome sequencing from two large biobanks (UK Biobank and All of Us). - Four classes of genetic variation were evaluated: rare germline variants in **inherited error of immunity** genes, common germline variants linked to **systemic lupus erythematosus** (SLE), somatic variants associated with hematological malignancies, and somatic variants underlying **clonal hematopoiesis**. - Each of the four variant types independently increased risk for immune cytopenia; their respective contributions and interactions were systematically assessed across cohorts. - Carriers of variants in some autosomal recessive inherited-immunity genes showed elevated immune cytopenia risk. - A polygenic or common-variant risk for SLE also conferred increased immune cytopenia risk in the studied populations. - Overall, between one-third and one-half of patients with immune cytopenia carried at least one of the four investigated genetic risk variant types. - Combining the four genetic risk categories enabled risk stratification: in the general population the estimated 10-year incidence ranged from 0.08% in the lowest-risk group to 1.5% in the highest-risk group. - Risk stratification was demonstrated both in general-population samples and in higher-risk subgroups. - Data supporting the analysis came from licensed access to UK Biobank and All of Us; code for analyses is available on the authors’ GitHub repository. - Ethical approvals and participant consent were obtained; one author disclosed unrelated industry funding and a research scholarship; other authors declared no competing financial interests.
## Clinical Analysis & Structured Key Points
Rare and Common Germline and Somatic Variants Shape Immune Cytopenia Risk and Enable Risk Stratification | medRxiv Skip to main content Rare and Common Germline and Somatic Variants Shape Immune Cytopenia Risk and Enable Risk Stratification Stennio Da Silva Faria , Julie Bineau , Rafael Moisan , Marc-Andre Legault , Estelle Lecluze , View ORCID Profile Thomas Pincez doi: https://doi.org/10.64898/2026.08.26.26361484 Stennio Da Silva Faria 1 CHU Sainte-Justine Azrieli Research Center, Montreal, Quebec, Canada; Faculty of Medicine, Universite de Montreal, Montreal, Quebec, Canada; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Julie Bineau 1 CHU Sainte-Justine Azrieli Research Center, Montreal, Quebec, Canada; Faculty of Medicine, Universite de Montreal, Montreal, Quebec, Canada; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Rafael Moisan 2 Faculty of Medicine, Universite de Montreal, Montreal, Quebec, Canada; Division of Pediatric Hematology-Oncology, CHU Sainte-Justine, Montreal, Quebec, Canada; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Marc-Andre Legault 3 CHU Sainte-Justine Azrieli Research Center, Montreal, Quebec, Canada; Faculty of Pharmacy, Universite de Montreal, Montreal, Quebec, Canada; Find this author on Google Scholar Find this author on PubMed Search for this author on this site Estelle Lecluze 4 CHU Sainte-Justine Azrieli Research Center, Montreal, Quebec, Canada Find this author on Google Scholar Find this author on PubMed Search for this author on this site Thomas Pincez 1 CHU Sainte-Justine Azrieli Research Center, Montreal, Quebec, Canada; Faculty of Medicine, Universite de Montreal, Montreal, Quebec, Canada; Find this author on Google Scholar Find this author on PubMed Search for this author on this site ORCID record for Thomas Pincez For correspondence: thomas.pincez{at}umontreal.ca Abstract Info/History Metrics Supplementary material Data/Code Preview PDF Abstract The genetic risk factors of immune cytopenias are unclear. Immune cytopenias have been reported in various genetic contexts: 1) inherited error of immunity genes, mainly due to rare germline variants, 2) systemic lupus erythematosus, associated with common germline variants, 3) hematological malignancies, and 4) clonal hematopoiesis, the latter two due to somatic variants. However, the respective contribution and interaction of these variants remain to be investigated. Here, we used two large biobanks with whole genome sequencing data to systematically investigate the genetic contribution to immune cytopenia. We found that the four types of genetic variants independently contribute to immune cytopenia risk. We notably found that carriers of variants in some autosomal recessive genes of inherited error of immunity had an increased risk of immune cytopenia. Additionally, common variant-mediated risk of systemic lupus erythematosus also increased the risk of immune cytopenia. Overall, a third to a half of patients with immune cytopenia carried at least one of the four genetic risk variants investigated. Combining the four variants allowed stratifying the risk of immune cytopenia in both general and high-risk population. In general population, the 10-year incidence of immune cytopenia in the lowest and highest risk groups was 0.08% and 1.5%, respectively. In sum, this work identified that different genetic risk factors can lead to immune cytopenia. A large proportion of individuals with immune cytopenia carried an underlying genetic risk factor. Finally, combining these genetic risk factors enabled risk stratification. Competing Interest Statement T.P. is a recipient of a FRQ (Fonds de Recherche du Quebec) Clinical Research Scholar and has received research funding from Biossil Inc., unrelated to the topic. The other authors declare no competing financial interests. Author Declarations I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained. Yes The details of the IRB/oversight body that provided approval or exemption for the research described are given below: Ethic committee of the CHU Sainte Justine gave ethical approval for this work I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals. Yes I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance). Yes I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable. Yes Data Availability The data that support the findings of this study are available from the UK Biobank and All of Us Program. Restrictions apply to the availability of these data, which were used under license for this study. Data are available from https://www.ukbiobank.ac.uk/ and https://www.researchallofus.org/ with permission from the UK Biobank and All of Us Program. This research has been conducted using the UK Biobank Resource under Application Number 399545. Code used for this study is available in github (https://github.com/steniorj/genetic_contributors_aic). https://github.com/steniorj/genetic_contributors_aic Copyright The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license . Back to top Previous Next Posted August 31, 2026. Download PDF Supplementary Material Data/Code Email Thank you for your interest in spreading the word about medRxiv. NOTE: Your email address is requested solely to identify you as the sender of this article. Your Email * Your Name * Send To * Enter multiple addresses on separate lines or separate them with commas. You are going to email the following Rare and Common Germline and Somatic Variants Shape Immune Cytopenia Risk and Enable Risk Stratification Message Subject (Your Name) has forwarded a page to you from medRxiv Message Body (Your Name) thought you would like to see this page from the medRxiv website. Your Personal Message CAPTCHA This question is for testing whether or not you are a human visitor and to prevent automated spam submissions. Share Rare and Common Germline and Somatic Variants Shape Immune Cytopenia Risk and Enable Risk Stratification Stennio Da Silva Faria , Julie Bineau , Rafael Moisan , Marc-Andre Legault , Estelle Lecluze , Thomas Pincez medRxiv 2026.08.26.26361484; doi: https://doi.org/10.64898/2026.08.26.26361484 Share This Article: Copy Citation Tools Rare and Common Germline and Somatic Variants Shape Immune Cytopenia Risk and Enable Risk Stratification Stennio Da Silva Faria , Julie Bineau , Rafael Moisan , Marc-Andre Legault , Estelle Lecluze , Thomas Pincez medRxiv 2026.08.26.26361484; doi: https://doi.org/10.64898/2026.08.26.26361484 Citation Manager Formats BibTeX Bookends EasyBib EndNote (tagged) EndNote 8 (xml) Medlars Mendeley Papers RefWorks Tagged Ref Manager RIS Zotero Tweet Widget Facebook Like Google Plus One Subject Area Hematology Subject Areas All Articles Addiction Medicine (613) Allergy and Immunology (894) Anesthesia (325) Cardiovascular Medicine (4757) Dentistry and Oral Medicine (474) Dermatology (406) Emergency Medicine (641) Endocrinology (including Diabetes Mellitus and Metabolic Disease) (1612) Epidemiology (15817) Forensic Medicine (32) Gastroenterology (1194) Genetic and Genomic Medicine (6973) Geriatric Medicine (727) Health Economics (1055) Health Informatics (4968) Health Policy (1423) Health Systems and Quality Improvement (1732) Hematology (579) HIV/AIDS (1332) Infectious Diseases (except HIV/AIDS) (16235) Intensive Care and Critical Care Medicine (1160) Medical Education (661) Medical Ethics (150) Nephrology (718) Neurology (7174) Nursing (363) Nutrition (1072) Obstetrics and Gynecology (1228) Occupational and Environmental Health (999) Oncology (3566) Ophthalmology (1034) Orthopedics (393) Otolaryngology (446) Pain Medicine (464) Palliative Medicine (139) Pathology (702) Pediatrics (1772) Pharmacology and Therapeutics (731) Primary Care Research (758) Psychiatry and Clinical Psychology (5821) Public and Global Health (9670) Radiology and Imaging (2380) Rehabilitation Medicine and Physical Therapy (1429) Respiratory Medicine (1239) Rheumatology (633) Sexual and Reproductive Health (763) Sports Medicine (573) Surgery (764) Toxicology (107) Transplantation (302) Urology (285)
## Related Clinical Research

- [Mean Platelet Volume and Disease Severity in Paediatric Sickle Cell Anaemia in Kwara State, Nigeria](https://medichelpline.com/clinical-feed/medrxiv-18-evaluating-mean-platelet-volume-in-relation-to-disease-severity-in-paediatric.md)
- [North West London Diabetes Cohort: multiethnic EHR resource for diabetes complications research](https://medichelpline.com/clinical-feed/bmj-open-2-large-scale-multiethnic-electronic-health-record-resource-for-diabetes.md)
- [Time-Dependent Diffusion MRI Framework for Clinical Brain Microstructure Characterisation](https://medichelpline.com/clinical-feed/medrxiv-2-a-time-dependent-diffusion-mri-framework-for-clinical-characterisation-of-human.md)
- [Readers’ reactions: M.D. vs D.O., AI and physician autonomy, surrogacy, postpartum psychiatry, and](https://medichelpline.com/clinical-feed/stat-news-0-opinion-what-stat-readers-think-about-m-d-vs-d-o-ai-in-medicine-surrogacy-and.md)
- [Which interventions affect biological aging? Epigenetic study finds diet, exercise, and some drugs](https://medichelpline.com/clinical-feed/medical-news-today-0-what-can-and-can-t-slow-down-aging-new-study-offers-clues.md)

## Navigation
- [← Back to Hematology Feed](https://medichelpline.com/clinical-feed/hematology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.